Mytos
London
About Mytos
Mytos is building a fully-automated cell manufacturing platform for biotech, starting with the drug development industry
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $20.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2023)
- Website: mytos.bio
Industries & Categories
Biotechnology, Hardware, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/mytos-18737 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.